Accelerate Diagnostics (axdx 5 12/15/26)
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$0.15avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Accelerate Diagnostics (axdx 5 12/15/26) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was Wolverine Asset Management LLC ($639K).
- Company
- Accelerate Diagnostics (axdx 5 12/15/26)
- CUSIP
- 00430HAC6
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 104,464 shares bought, net +104,464 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Wolverine Asset Management LLC | 0.06% | Add +2.5% | 4,283,024 | $639K |
"% of holder's portfolio" is ACCELERATE DIAGNOSTICS (AXDX 5 12/15/26)'s weight in each manager's 13F, not the share of Accelerate Diagnostics (axdx 5 12/15/26) the manager owns.